Enzyme Multiplied Immunoassay Technique

This MedLibrary.org supplementary page on Enzyme Multiplied Immunoassay Technique is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Enzyme multiplied immunoassay technique, or EMIT, is a common method for screening urine and blood for drugs, whether legal or illicit. It is part of the homogeneous immunoassay.

The technique is relatively nonspecific compared to some other analysis methods, such as mass spectrometry, but has the advantage of being fast and inexpensive. It has, however, been shown in some cases to be somewhat inaccurate in its findings. The patent for EMIT technology was owned by the Syva Corporation, Palo Alto, CA, but was sold in March 2005 to ORAK Corp, San Francisco.

See also

References


External links

Wikipedia content modification information:

  • This page was last modified on 16 March 2008, at 23:05.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Enzyme Multiplied Immunoassay Technique".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.